FDA Approves Tiratricol as First Treatment for MCT8 Deficiency
Emcitate (tiratricol) is approved to treat peripheral thyrotoxicosis in people with MCT8 deficiency, a rare genetic disorder also called Allan-Herndon-Dudley syndrome.
Genetics & Precision Medicine
Blood Test Can Now Trigger Earlier Treatment Change in Advanced Breast Cancer
FDA has approved a treatment strategy that uses tumour DNA found in blood to detect drug resistance and change therapy before ordinary scans show that the cancer is worsening.